Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial.
Short NJ, Nguyen D, Jabbour E, Senapati J, Zeng Z, Issa GC, Abbas H, Nasnas C, Qiao W, Huang X, Borthakur G, Chien K, Haddad FG, Pemmaraju N, Karrar OS, Nguyen D, Konopleva M, Kantarjian H, Ravandi F.
Short NJ, et al. Among authors: abbas h.
Lancet Haematol. 2024 Sep 17:S2352-3026(24)00250-3. doi: 10.1016/S2352-3026(24)00250-3. Online ahead of print.
Lancet Haematol. 2024.
PMID: 39303729